Skip to main content
. Author manuscript; available in PMC: 2020 Mar 12.
Published in final edited form as: Metabolomics. 2019 Mar 12;15(3):43. doi: 10.1007/s11306-019-1505-6

Table 1.

Patient characteristics

Healthy
(n=15)
Wilson Disease
(n=61)
p-value
Males
(n=5)
Females
(n=10)
Malesa
(n=31)
Females
(n=30)
Age (years),
mean ± SD
34.4 ± 11.4 37.7 ± 10.0 35.7 ± 10.5 32.3 ± 13.2 0.5926b
0.2408c
BMI (kg/m2),
mean ± SD
26.6 ± 3.9 22.0 ± 3.0 26.4 ± 6.2 25.0 ± 3.3 0.9351b
0.0139c
Hepatic phenotype,
n (% total WD)
N/A N/A 12 (20.0%) 14 (23.3%) N/A
Neurologic phenotype,
n (% total WD)
N/A N/A 13 (21.7%) 9 (15.0%) N/A
Preclinical,
n (% total WD)
N/A N/A 5 (8.3%) 7 (11.7%) N/A
a

Phenotype not available for one patient.

b

males

c

females.

BMI, body mass index.